![James Ballance](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Ballance
Keine laufenden Positionen mehr
Profil
James Ballance worked as a Director of Business Development at Aventis Behring from 1999 to 2001.
He was the Vice President of Scientific Affairs at PhaseBio Pharmaceuticals, Inc. in 2013 and 2014.
He was also the Head of Research and Development at Delta Biotechnology Ltd. Additionally, he worked as the Vice President of Technology Development at BioRexis Pharmaceutical Corp.
from 2003 to 2007.
Dr. Ballance received his undergraduate degree from the University of Wales (Bangor) in 1981 and his doctorate from the University of Bristol in 1984.
Ehemalige bekannte Positionen von James Ballance
| Unternehmen | Position | Ende |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2007 |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | 01.01.2001 |
| PHASEBIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Produces and markets a range of valuable proteins from yeast using low cost manufacturing technologies | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James Ballance
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Produces and markets a range of valuable proteins from yeast using low cost manufacturing technologies | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of Wales (Bangor)
 University of Wales (Bangor) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Health Technology |
